SHARONBIO — Sharon Bio-Medicine Balance Sheet
0.000.00%
HealthcareMicro Cap
Annual balance sheet for Sharon Bio-Medicine, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2015 June 30th | 2016 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | PRESS | PRESS | PRESS |
| Standards: | IAS | IAS | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 90.1 | 40.7 | 319 | 516 | 900 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,526 | 2,049 | 293 | 269 | 261 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,700 | 3,951 | 1,395 | 1,549 | 1,758 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,321 | 3,186 | 1,415 | 1,348 | 1,281 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 10,120 | 7,228 | 2,902 | 2,991 | 3,130 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,619 | 3,377 | 3,511 | 3,429 | 3,391 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8,935 | 9,043 | 9,157 | 9,084 | 9,034 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,185 | -1,815 | -6,255 | -6,092 | -5,903 |
| Total Liabilities & Shareholders' Equity | 10,120 | 7,228 | 2,902 | 2,991 | 3,130 |
| Total Common Shares Outstanding |